Cory David A 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-03-11+281,000→ 281,000 totalExercise: $5.10Exp: 2032-03-10→ Common Stock (281,000 underlying) - Award
Common Stock
2022-03-11+47,000→ 169,183 total
Footnotes (3)
- [F1]Represents shares underlying Restricted Stock Units award that will vest as to 33.3% on each of the first, second and third anniversaries of the grant date of March 11, 2022.
- [F2]The option vests in 48 equal monthly installments commencing on the grant date of March 11, 2022, subject to the Reporting Person's continuous service as of such date.
- [F3]Includes shares purchased under the Issuer's Employee Stock Purchase Plans as follows: 1,378 shares on September 5, 2020, 1,459 shares on September 3, 2021, and 1,500 shares on March 5, 2022.